144 related articles for article (PubMed ID: 34167944)
1. Morphological characteristics preceding exudative neovascularisation secondary to macular telangiectasia type 2.
Hess K; Charbel Issa P; Holz FG; Tzaridis S
Br J Ophthalmol; 2022 Dec; 106(12):1736-1741. PubMed ID: 34167944
[TBL] [Abstract][Full Text] [Related]
2. Optical coherence tomography-angiography for monitoring neovascularisations in macular telangiectasia type 2.
Tzaridis S; Hess K; Friedlander M; Holz FG
Br J Ophthalmol; 2021 May; 105(5):735-740. PubMed ID: 32513667
[TBL] [Abstract][Full Text] [Related]
3. Right-angled vessels in macular telangiectasia type 2.
Tzaridis S; Heeren T; Mai C; Thiele S; Holz FG; Charbel Issa P; Herrmann P
Br J Ophthalmol; 2021 Sep; 105(9):1289-1296. PubMed ID: 30808615
[TBL] [Abstract][Full Text] [Related]
4. Progression of vascular changes in macular telangiectasia type 2: comparison between SD-OCT and OCT angiography.
Pauleikhoff D; Gunnemann F; Book M; Rothaus K
Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1381-1392. PubMed ID: 31093765
[TBL] [Abstract][Full Text] [Related]
5. OCT of Outer Retinal Hyperreflectivity, Neovascularization, and Pigment in Macular Telangiectasia Type 2.
Krivosic V; Lavia C; Aubineau A; Tadayoni R; Gaudric A
Ophthalmol Retina; 2021 Jun; 5(6):562-570. PubMed ID: 32956858
[TBL] [Abstract][Full Text] [Related]
6. Epiretinal Neovascularization: A Novel OCT Angiography Finding in Macular Telangiectasia Type 2.
Ayachit AG; Reddy LU; Joshi S; Ayachit GS
Ophthalmol Retina; 2019 Jun; 3(6):516-522. PubMed ID: 31174674
[TBL] [Abstract][Full Text] [Related]
7. Staging of macular telangiectasia: power-Doppler optical coherence tomography and macular pigment optical density.
Chin EK; Kim DY; Hunter AA; Pilli S; Wilson M; Zawadzki RJ; Werner JS; Park SS
Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4459-70. PubMed ID: 23716628
[TBL] [Abstract][Full Text] [Related]
8. Tamoxifen Retinopathy and Macular Telangiectasia Type 2: Similarities and Differences on Multimodal Retinal Imaging.
Hess K; Park YJ; Kim HA; Holz FG; Charbel Issa P; Yoon YH; Tzaridis S
Ophthalmol Retina; 2023 Feb; 7(2):101-110. PubMed ID: 35948211
[TBL] [Abstract][Full Text] [Related]
9. OUTER FOVEAL DEFECTS IN TYPE-2 MACULAR TELANGIECTASIA.
Chandran K; Giridhar A; Gayathri MS; Antison M; Gopalakrishnan M; Sivaprasad S
Retina; 2023 Jan; 43(1):111-119. PubMed ID: 36542082
[TBL] [Abstract][Full Text] [Related]
10. Multimodal Imaging of Macular Telangiectasia Type 2: Focus on Vascular Changes Using Optical Coherence Tomography Angiography.
Toto L; Di Antonio L; Mastropasqua R; Mattei PA; Carpineto P; Borrelli E; Rispoli M; Lumbroso B; Mastropasqua L
Invest Ophthalmol Vis Sci; 2016 Jul; 57(9):OCT268-76. PubMed ID: 27409482
[TBL] [Abstract][Full Text] [Related]
11. Incidence and phenotypical variation of outer retina-associated hyperreflectivity in macular telangiectasia type 2.
Mueller S; Gunnemann F; Rothaus K; Book M; Faatz H; Bird A; Pauleikhoff D
Br J Ophthalmol; 2021 Apr; 105(4):573-576. PubMed ID: 33414243
[TBL] [Abstract][Full Text] [Related]
12. MACULAR TELANGIECTASIA TYPE 2: Acircularity Index and Quantitative Assessment of Foveal Avascular Zone Using Optical Coherence Tomography Angiography.
Ersoz MG; Hocaoglu M; Sayman Muslubas I; Arf S; Karacorlu M
Retina; 2020 Jun; 40(6):1132-1139. PubMed ID: 30893277
[TBL] [Abstract][Full Text] [Related]
13. CHARACTERIZING RETINAL-CHOROIDAL ANASTOMOSIS IN MACULAR TELANGIECTASIA TYPE 2 WITH OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.
Breazzano MP; Yannuzzi LA; Spaide RF
Retina; 2020 Jan; 40(1):92-98. PubMed ID: 31246676
[TBL] [Abstract][Full Text] [Related]
14. Fundus Autofluorescence Imaging in Macular Telangiectasia Type 2: MacTel Study Report Number 9.
Pauleikhoff L; Heeren TFC; Gliem M; Lim E; Pauleikhoff D; Holz FG; Clemons T; Balaskas K; ; Egan CA; Charbel Issa P
Am J Ophthalmol; 2021 Aug; 228():27-34. PubMed ID: 33775659
[TBL] [Abstract][Full Text] [Related]
15. Progression characteristics of ellipsoid zone loss in macular telangiectasia type 2.
Pauleikhoff D; Bonelli R; Dubis AM; Gunnemann F; Rothaus K; Charbel Issa P; Heeren TF; Peto T; Clemons TE; Chew EY; Bird AC; Sallo FB;
Acta Ophthalmol; 2019 Nov; 97(7):e998-e1005. PubMed ID: 30968592
[TBL] [Abstract][Full Text] [Related]
16. Macular Pigment Distribution as Prognostic Marker for Disease Progression in Macular Telangiectasia Type 2.
Müller S; Charbel Issa P; Heeren TFC; Thiele S; Holz FG; Herrmann P
Am J Ophthalmol; 2018 Oct; 194():163-169. PubMed ID: 30053477
[TBL] [Abstract][Full Text] [Related]
17. Relation of interdigitation zone changes and right-angle vessels in Macular Telangiectasia Type-2 (MacTel).
Chandran K; Giridhar A; Gopalakrishnan M; Sivaprasad S
Eye (Lond); 2023 Oct; 37(14):2977-2986. PubMed ID: 36841866
[TBL] [Abstract][Full Text] [Related]
18. Distribution of macular pigments in macular telangiectasia type 2 and correlation with optical coherence tomography characteristics and visual acuity.
Srinivasan R; Teussink MM; Sloan KR; Bharat RPK; Narayanan R; Raman R
BMC Ophthalmol; 2022 Jun; 22(1):264. PubMed ID: 35698056
[TBL] [Abstract][Full Text] [Related]
19. EARLY SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY BIOMARKERS TO CONFIRM FELLOW EYE CHANGES IN ASYMMETRIC TYPE-2 MACULAR TELANGIECTASIA: A Case-Control Study (India Macular Telangiectasia Report 1).
Alex D; Giridhar A; Gopalakrishnan M; Manayath G; Amar S; Raman R; Sreenivasan R; Ayachit A; Sivaprasad S
Retina; 2021 Mar; 41(3):471-479. PubMed ID: 32804830
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Optical Coherence Tomography With Fundus Photographs, Fluorescein Angiography, and Histopathologic Analysis in Assessing Coats Disease.
Ong SS; Cummings TJ; Vajzovic L; Mruthyunjaya P; Toth CA
JAMA Ophthalmol; 2019 Feb; 137(2):176-183. PubMed ID: 30476946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
